KPE 02004001 - DO NOT RELEASE PROBIOTIC

Drug Profile

KPE 02004001 - DO NOT RELEASE PROBIOTIC

Alternative Names: KPE02004; KPE02004001

Latest Information Update: 10 Aug 2006

Price : $50

At a glance

  • Originator Kemin Pharma
  • Class Antibacterials
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Phase I Clostridium infections; Diarrhoea

Most Recent Events

  • 06 Jul 2006 The Belgian Ministry of Health has approved the initiation of a double-blind, placebo-controlled trial of KPE 02004001 for Clostridium difficile-associated diarrhoea
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top